Antiretroviral Therapy Adherence Enhancing Interventions for Adolescents and Young Adults 13-24 Years of Age: A Review of the Evidence Base

Sarah Shaw, K Rivet Amico, Sarah Shaw, K Rivet Amico

Abstract

Introduction: Youth living with HIV are highly under-represented in the evidence base for adherence interventions, despite their diverse and unique needs and barriers.

Objective: This systematic review aimed to identify antiretroviral therapy (ART) adherence interventions specifically targeting adolescents and young adults (defined as ages 13-24) with the goal of characterizing the evidence base.

Methods: Articles were identified using the PubMed database and cover work published through September 14, 2015.

Inclusion criteria: (1) average age 13 to 24, (2) HIV positive, (3) on or beginning ART, (4) intervention targeted ART adherence in full or in part, (5) reported adherence, viral load, and/or CD4 count outcomes. Strength of evidence was defined as level 1 [randomized controlled trial (RCT) with significance testing on outcomes], 2 (within group studies with statistical testing on outcomes), 3 (RCTs with descriptive results), or 4 (within group studies with descriptive results).

Results: Of 151 articles, 10 met inclusion criteria. Published between 2003 and 2014, these studies evaluated diverse intervention approaches. Most were conducted in the US and were small pilots that have yet to be replicated despite promising results. Only 3 studies met criteria for highest level strength of evidence; 2 supported a phone-based counseling approach with adherence monitors and 1 for weekly individual and family counseling.

Conclusions: Despite nearly 20 years passing since the wide-scale availability of ART, and clear recognition that adolescents and youth adults fair worse on the cascade of HIV care, the evidence base remains sparse and underdeveloped. Promising approaches need replication and more rigorous studies are desperately needed.

Conflict of interest statement

K.R.A. is the recipient of a Gilead Sciences educational grant through the University of Michigan and has served on expert advisory panels for Pre-Exposure Prophylaxis with Gilead Sciences. The other author has no funding or conflicts of interest to disclose.

Figures

FIGURE 1.
FIGURE 1.
Flowchart for reviewed and included articles under searched term [(((((((structural) or ((behavioral) or behavioural))) and intervention)) and ((((((ART) or HIV medication) or HAART)) and ((adherence) or persistence)) and HIV))) and (((young adult) or adolescent) or adolescence)]. HAART, highly active antiretroviral therapy.

References

    1. Bangsberg DR, Moss AR, Deeks SG. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J Antimicrob Chemother. 2004;53:696–699.
    1. Jensen-Fangel S, Pedersen L, Pedersen C, et al. Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population. AIDS. 2004;18:89–97.
    1. Palella FJ, Jr, Deloria-Knoll M, Chmiel JS, et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med. 2003;138:620–626.
    1. Kim SH, Gerver SM, Fidler S, et al. Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis. AIDS. 2014;28:1945–1956.
    1. Lall P, Lim SH, Khairuddin N, et al. Review: an urgent need for research on factors impacting adherence to and retention in care among HIV-positive youth and adolescents from key populations. J Int AIDS Soc. 2015;18(2 suppl 1):19393.
    1. Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDS. 2014;28:128–135.
    1. Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012;156:817–833.
    1. UNAIDS. Adolscents and Young People Fact Sheet; 2012. Available at: . Accessed November 30, 2015.
    1. Centers for Disease Control and Prevention. HIV Among Youth; 2015. Available at: . Accessed January 28, 2016.
    1. Yang Y. State of the science: the efficacy of a multicomponent intervention for ART adherence among people living with HIV. J Assoc Nurses AIDS Care. 2014;25:297–308.
    1. Horvath T, Azman H, Kennedy GE, et al. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Syst Rev. 2012;3:CD009756.
    1. Simoni JM, Frick PA, Pantalone DW, et al. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11:185–198.
    1. Centers for Disease Control and Prevention. Compendium of Evidence-based Interventions and Best Practices for HIV Prevention: The Complete Medication Adherence Chapter; 2014. Available at: . Accessed December 30, 2015.
    1. MacPherson P, Munthali C, Ferguson J, et al. Service delivery interventions to improve adolescents' linkage, retention and adherence to antiretroviral therapy and HIV care. Trop Med Int Health. 2015;20:1015–1032.
    1. Steinberg L. Cognitive and affective development in adolescence. Trends Cogn Sci. 2005;9:69–74.
    1. Reisner SL, Mimiaga MJ, Skeer M, et al. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med. 2009;17:14–25.
    1. Tsang SK, Hui EK, Law BC. Positive identity as a positive youth development construct: a conceptual review. ScientificWorldJournal. 2012;2012:529691.
    1. Meeus W, van de Schoot R, Keijsers L, et al. Identity statuses as developmental trajectories: a five-wave longitudinal study in early-to-middle and middle-to-late adolescents. J Youth Adolesc. 2012;41:1008–1021.
    1. De Leo G, LeRouge C, Ceriani C, et al. Websites most frequently used by physician for gathering medical information. AMIA Annu Symp Proc. 2006:902.
    1. Dowshen N, D'Angelo L. Health care transition for youth living with HIV/AIDS. Pediatrics. 2011;128:762–771.
    1. Rongkavilit C, Naar-King S, Wang B, et al. Motivational interviewing targeting risk behaviors for youth living with HIV in Thailand. AIDS Behav. 2013;17:2063–2074.
    1. Belzer ME, Naar-King S, Olson J, et al. The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial. AIDS Behav. 2014;18:686–696.
    1. Lyon M, Trexler C, Akpan-Townsend C, et al. A family group approach to increasing adherence to therapy in HIV infected youths: results of a pilot project. AIDS Patient Care STDS. 2003;17:299–308.
    1. Naar-King S, Outlaw AY, Sarr M, et al. Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment. J Pediatr Psychol. 2013;38:638–648.
    1. Letourneau EJ, Ellis DA, Naar-King S, et al. Multisystemic therapy for poorly adherent youth with HIV: results from a pilot randomized controlled trial. AIDS Care. 2013;25:507–514.
    1. Gray WN, Janicke DM, Fennell EB, et al. Piloting behavioral family systems therapy to improve adherence among adolescents with HIV: a case series intervention study. J Health Psychol. 2011;16:828–842.
    1. Foster C, McDonald S, Frize G, et al. “Payment by Results”—financial incentives and motivational interviewing, adherence interventions in young adults with perinatally acquired HIV-1 infection: a pilot program. AIDS Patient Care STDS. 2014;28:28–32.
    1. Dowshen N, Kuhns LM, Johnson A, et al. Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. J Med Internet Res. 2012;14:e51.
    1. Gaur AH, Belzer M, Britto P, et al. Directly observed therapy (DOT) for nonadherent HIV-infected youth: lessons learned, challenges ahead. AIDS Res Hum Retroviruses. 2010;26:947–953.
    1. Puccio J, Belzer M, Olson J, et al. Use of cell phone reminder calls for assisting HIV infected adolescents and young adults to Adhere to high active antiretroviral therapy: a pilot study. AIDS Patient Care STDS. 2006;20:438–444.
    1. Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41:285–297.
    1. Shaw C, Brady LM, Davey C. Guidelines for Research with Children and Young People. London, United Kingdom: National Children's Bureau Research Centre; 2011.
    1. DiClemente RJ, Sales JM, Borek N. Barriers to adolescents' participation in HIV biomedical prevention research. J Acquir Immune Defic Syndr. 2010;54(suppl 1):S12.
    1. Brawner BM, Volpe EM, Stewart JM, et al. Attitudes and beliefs toward biobehavioural research participation: voices and concerns of urban adolescent females receiving outpatient mental health treatment. Ann Hum Biol. 2013;40:485–495.
    1. Cohen MS, Dye C, Fraser C, et al. HIV treatment as prevention: debate and commentary—will early infection compromise treatment-as-prevention strategies? PLoS Med. 9:e1001232.
    1. Mayer K, Gazzard B, Zuniga JM, et al. Controlling the HIV epidemic with antiretrovirals IAPAC consensus statement on treatment as prevention and preexposure prophylaxis. J Int Assoc Providers AIDS Care. 2013;12:208–216.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe